This review evaluated the efficacy and safety of parenteral estrogen therapy among prostate cancer patients undergoing androgen deprivation therapy.

The authors aimed to determine the prognostic (treatment outlook) value of genetic expression (the expression of genes) on breast cancer survival.

This study examined the effectiveness of combined androgen blockade in the treatment of prostate cancer.

The authors aimed to determine the negative effects of hormone therapy and ways to avoid these effects in prostate cancer patients.

This study investigated the relationship between lactate dehydrogenase (LDH) levels and cancer-specific survival.

Researchers concluded that LDH can be used as an early indicator of cancer outcomes.

This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy.

According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be offered a three-drug combination of an NK1-receptor antagonist, a 5-HT3 receptor antagonist, and dexamethasone.

NEPA combination (Akynzeo) plus dexamethasone is a safe and effective treatment option in this setting.

This article evaluated the benefits of psychology treatments for breast cancer patients with depression.

This study examined the effectiveness of pubic bone removal on pain intensity associated with an infected pubic bone in prostate cancer survivors. Authors concluded that surgical treatment is an effective approach in providing long-term pain relief from an infected pubic bone.

This study evaluated the use of statins among breast cancer patients.

This paper studied the knowledge and attitudes of primary care providers towards providing survivorship care to patients with breast cancer.